This is a preview of subscription content, log in via an institution to check access.
Notes
This profile has been selected from R&D Insight™, a pharmaceutical intelligence database produced by Adis International Ltd.
References
Novavax Inc. Novavax, Inc. initiates combination study of ANDROSORB (TM) and ESTRASORB (TM) in hormone deficient women. Media Release: 27 Mar 2002. Available from URL: http://www.novavax.com
Novavax Inc. Novavax presents results of Estrasorb (TM) phase II clinical trial in symptomatic postmenopausal women. Media Release: [2 pages], 18 Jun 1999. Available from URL: http://www.novavax.com
Novavax Inc. Novavax presents results of a phase III clinical trial using ESTRASORB (TM) at Society for Gynecologic Investigation Meeting. Media Release: 22 Mar 2002. Available from URL: http://www.novavax.com
Wyeth Pharmaceuticals. Wyeth informs physicians of WHI Findings. Media Release: 9 Jul 2002. Available from URL: http://www.wyeth.com
Novavax Inc. Novavax, Inc. Comments on recent hormone replacement therapy study. Media Release: 11 Jul 2002. Available from URL: http://www.novavax.com
Novavax Inc. Results of Phase III Clinical Trial Reveal Estrasorb(TM) (Estradiol Topical Emulsion) Is Effective in Reducing Vasomotor Symptoms in Post Menopausal Women. Media Release: 4 Oct 2002. Available from URL: http://www.novavax.com
Rights and permissions
About this article
Cite this article
Estradiol-Topical — Novavax. Drugs in R&D 4, 49–51 (2003). https://doi.org/10.2165/00126839-200304010-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00126839-200304010-00008